Share Name Share Symbol Market Type Share ISIN Share Description
Prophotonix LSE:PPIX London Ordinary Share US7434651060 COM SHS $0.001 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 9.25p 9.00p 9.50p 9.25p 9.25p 9.25p 50,000 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic & Electrical Equipment 13.2 1.0 1.2 8.0 7.04

Prophotonix Share Discussion Threads

Showing 201 to 224 of 225 messages
Chat Pages: 9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
20/7/2017
08:06
Strong trading in the photonics division at IQE bodes well for PPIX. We've invested future growth and can sit back and enjoy a return on that investment over the coming months.
greedy rooster
19/7/2017
08:06
I take it you didn't sell well.
greedy rooster
18/7/2017
16:37
Yes but if you can't even get the name right in your header Who is going to take any note of what you say ? This is a very basic error and shows lack of attention to detail ......... 4/10 ProPhotonix....... Lighting the way ahead
buywell3
18/7/2017
16:12
Good to see solid volume today, edging back up - still cheap and up for sale as far as I'm concerned.
greedy rooster
17/7/2017
07:48
Re ''However, sales, general and administrative (SG&A) costs in the second half of 2017 are expected to increase due to the award of stock options, as announced on June 6, 2017. These stock option awards are predominantly performance based with vesting tied to specific management objectives. These non-cash stock compensation costs are expected to amount to approximately $100,000 per month based on the market value at the time of the awards'' 1. How long are the monthly $100k stock option awards , (linked to shareholders buying PPIX shares to push it to 18.5p), going to go on for ? 2. These awards are going to punish shareholders for buying PPIX shares and raising the share price because they will result in dilution to shareholders. 3. How does the awards of these 100K a months stock options unknown time limit) impact upon sales,general and administrative (SG&A) costs ? 4. When does/did the $100K stock option award start ? 5. What share price price will trigger another round of these stock option awards to punish shareholders for buying PPIX ?
buywell3
14/7/2017
11:50
Oh dear You have been forwood (cursed). Call the funeral director.
captain of the titanic
14/7/2017
10:29
What, trading in line with expectations 'kills' your potential investment - good luck!
greedy rooster
14/7/2017
10:07
Its always a danger to have a few customers making up a large proportion of sales. I worked for a small company where 20% of orders for two years were from one customer who had a one off product. When that stopped it suddenly made our sales look very poor and we lost the supplier contract. A typical use of the laser diode is as a robotic sensor - essentially it switches on/off when the robot reaches the home position or the edge of its movement. Many other similar sensing applications too. Without knowing the product that was replaced with different tech its impossible to know whether this was a one off loss or if its now outdated (I'd tend to think the former) My concern here is that the company is being run for the benefit of the directors rather than the shareholders - its fair to say this update has killed my potential investment, but good luck to those that remain.
dr biotech
14/7/2017
09:43
Cobra products due for sale from Q3. This puppy looks fine.
greedy rooster
14/7/2017
09:31
Even with the loss of the customer, revenue was up 4% in the period.
rcturner2
14/7/2017
09:29
Now that the price of PPIX shares has fallen from 18.5p (early June) to 8.5p, the award of 12,870,000 options at 23.85c, say 18.5p, does not seem such as generous as it did. The treatment of this award in the Profit & Loss account should presumably be calculated in accordance with some formula in which one factor is the average share price during the accounting period. PPIX indicate a figure of $100,000 per month; will this relate to the last 6 months of 2017 or the whole year ? Unless the share price recovers soon, the average for 2017 is unlikely to exceed 10p, say 13c, in which case a fair value for the award might be 1c per option, say $128,700, and would be the charge for the full year and not just one month. So I find the $100,000 per month figure perplexing. This is not, of course, a cash charge; it is just an unwelcome reduction of the share of profits going to outsiders like ourselves. The increase in expenditure on R&D and sales and loss of an important customer will affect our cash flow this year and seem more important than the award of options.
varies
14/7/2017
09:14
People selling? Why?
cezary2
14/7/2017
08:11
Down 31% on £13k worth of trades!! Completely unjustified and unfair
pauliewonder
14/7/2017
08:08
Trading in line, stock down 40% so back to a p/e of 6.
greedy rooster
14/7/2017
08:04
What is the alternative technology ? anyone know ''a decrease in sales to one large customer that converted to an alternate technology in the second quarter of 2017'' Could prove interesting, I will investigate
buywell3
14/7/2017
07:48
I agree with greedy roosters comments earlier, I think the for sale sign is up and they are giving cheap shares to mates first. Will be sold shortly.
pauliewonder
14/7/2017
07:42
hTTp://www.prophotonix.com/investors/Corporate-Governance/Board-of-directors.aspx This could cost $600K by the year end could it not ? ''These stock option awards are predominantly performance based with vesting tied to specific management objectives. These non-cash stock compensation costs are expected to amount to approximately $100,000 per month based on the market value at the time of the awards, which has risen threefold since the beginning of the 2017 (from 5.75p to 18.5p)'' and for what ? Orders for the second half with additional sales staff are up a measly $300k on last year I am ok with the award of share options , which were recently awarded at 18.5p , which meant the BOD had to get cracking However they have a fall-back to pay themselves now $100K a month Is that TOTAL for all of the BOD and for how long does this last ? Not Happy
buywell3
14/7/2017
07:28
Not the greatest trading statement. Lost a large customer...I did mention a while ago that some customers account for a large percentage of sales which is not a good position to be in. Paid off debt though, something I like to see.
dr biotech
14/7/2017
07:25
I am sorry to say there are a few things in this that I am not too happy about ProPhotonix Limited Trading update and extension of Rights Plan 14/07/2017 Trading update and extension of Rights Plan ProPhotonix Limited (London Stock Exchange - AIM: PPIX, OTC: STKR), a high technology designer and manufacturer of LED illumination systems and laser diode modules, with operations in Ireland and the United Kingdom, today announces a trading update and extension of the Rights Plan. Trading update First Half 2017 The Company's term debt has been fully repaid as of June 29, 2017. A total of $3.3 million of principal and interest was repaid since the notes were restructured in June, 2013. The remaining non-trade debts ($1.3 million) of the Company relate to equipment leases and the sales discount facility which has been in place for approximately nine years. Revenue for the first half 2017 is expected to be approximately $8.3 million, an increase of 4% over the 2016 comparable figure. The revenue growth stems from an increase in sales to several major customers, partially offset by a decrease in sales to one large customer that converted to an alternate technology in the second quarter of 2017. Operating income for the first half 2017 is expected to be approximately $500,000, a decrease of approximately $245,000 versus the 2016 comparable figure. The reduction in operating income results is a reflection of the investment the Company is making for the future growth of the business and from increased sales expenses from the hiring of additional staff in the fourth quarter of 2016, increased engineering and development costs associated with several large original equipment manufacturing ("OEM") projects, and the continuing investment in the UV LED product development. Second Half 2017 The order book for the second half 2017, as of June 30, 2017, is $6.0 million (2016: $5.7 million) and the Company continues to trade in line with market expectations for the full year. ProPhotonix does not provide forecasts without sufficient visibility to allow for reasonable certainty of the forecast. However, sales, general and administrative (SG&A) costs in the second half of 2017 are expected to increase due to the award of stock options, as announced on June 6, 2017. These stock option awards are predominantly performance based with vesting tied to specific management objectives. These non-cash stock compensation costs are expected to amount to approximately $100,000 per month based on the market value at the time of the awards, which has risen threefold since the beginning of the 2017 (from 5.75p to 18.5p). The free cash flow and EBITDA (earnings before interest, taxes, depreciation, amortization, stock-based compensation and impairment charges) as a non-GAAP financial measure, of the Company will not be negatively impacted for these charges. The Directors expect that the Company's unaudited interim results for the six months to 30 June 2017 will be released in early September 2017. Tim Losik, CEO of ProPhotonix, stated - "We continue to position ProPhotonix toward future revenue growth and profits. With the term debt repaid, we are making further investments in personnel, capital, and product development to enable the growth of the Company. These investments may depress the short term profitability though we expect will enhance future performance." Rights Plan The Board of Directors of ProPhotonix have unanimously approved extension of the Company's Rights Plan (the "Plan") until August 28, 2020. The Plan is designed to ensure that all shareholders of the Company realize the long-term value of their investment in the Company; that they receive fair and equal treatment in the event of a potential takeover of the Company; that they are protected in the event of any of a two-tier or partial tender offer, open market accumulations and other tactics designed to gain control of the Company without the payment of a fair price by an offeror; and to enhance the Board of Directors' ability to negotiate with a prospective acquirer. The Board determined that extension of the Plan is in the best interest of the Company's shareholders. The Plan and the extension of the Plan were adopted in accordance with Delaware law. As set out on the Company's website, the Company is not subject to the City Code on Takeovers and Mergers. A summary of the terms of the Plan, and a copy of the Plan as amended, are available on the Company's website at hxxp://www.prophotonix.com/investors/Stockinfo.aspx.
buywell3
07/7/2017
11:05
Edging up again. Looks set to march on ahead of results.
greedy rooster
04/7/2017
08:08
Strong statement from 600 Group this morning which will read well across for PPIX.
greedy rooster
29/6/2017
10:09
It could be that the BOD have seen the rise in share price in the UK V the 14 cents in the OTC USA market and are trying to hang in there. The UK market is now aligned with that in the USA
buywell3
29/6/2017
08:09
All of this trumpeting of success convinces me that the 'For Sale' sign is being put up.
greedy rooster
27/6/2017
22:35
Lots of $ earners hit...no chart support till 6p. Think I'll just continue to watch for now
dr biotech
Chat Pages: 9  8  7  6  5  4  3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170721 04:52:45